Olopatadine/ mometasone (Ryaltris)

Status:
Grey
Decision Date:
April 2022
 

Comments

GREY - for adults and adolescents 12 years of age and older for the treatment for moderate to severe seasonal and perennial allergic rhinitis. 

search again